Shapely

What Shapely does

Shapely is a Los-Angeles-based, physician-led telehealth company founded in 2023 that operates a direct-to-consumer weight loss platform serving adults 18 and older in California, Florida, New York, and Texas. The company delivers care through monthly video visits with board-certified weight loss providers and registered dietitians, prescriptions for GLP-1 and adjunct weight loss medications (semaglutide, tirzepatide, oral semaglutide, orforglipron, and bupropion/naltrexone), and a mobile app supporting food/activity tracking, 24/7 chat, and cellular-connected smart scale integration.

Its core technology is a telehealth platform comprising a web front-end for sign-up and insurance verification, a mobile app for tracking and care-team messaging, and video visit infrastructure connecting patients to clinicians and dietitians. There is no disclosed proprietary AI/ML capability; the technology stack is positioned as integrated workflow software rather than algorithmic differentiation. The product surface spans a Weight Loss Program and a parallel Nutrition Program, with a single brand positioning around insurance-covered medical weight management.

Shapely generates revenue primarily through recurring monthly memberships priced at $9 for insured members (first month) or $99 for self-pay members (first month $49), plus unit-priced compounded GLP-1 medications for cash-pay patients (semaglutide from $99/month, tirzepatide from $166/month), nutrition counseling visits at $125 self-pay, and flat-rate labs at $75. The go-to-market is direct-to-consumer via an educational blog, organic search, and patient testimonials, supported by in-network payer status with Medicare and major PPO insurers. Shapely is founder-owned by Dr. Justin Zaghi and operates with 11-50 employees; no parent company, subsidiaries, or institutional funding rounds are disclosed.

Name

Shapely

Legal name

Shapely

Website

https://getshapely.com

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

11–50 employees

Short description

Shapely is a physician-led telehealth platform that provides insurance-covered medical weight loss care, including video visits with obesity specialists, GLP-1 prescriptions, and registered dietitian support, serving adults seeking supervised weight management in four US states.

Ownership category

akta.pro rank

Product category

Telehealth Weight Loss

NAICS

Offices of Physicians (6211)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro industry

PRIMARYHLALAFAA

Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity)

Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms

SECONDARYHLAKADAL

Obesity Medicine & Weight Management

Healthcare & Life Sciences/Specialist Medical Practice/Endocrinology & Diabetes

SECONDARYHSADAFAE

Medical Nutrition Therapy (Registered Dietitian)

Home & Personal Services/Fitness, Wellness & Personal Training/Nutrition Coaching & Weight Management

SECONDARYHSADAGAH

Chronic Condition Lifestyle Coaching (Non-Clinical)

Home & Personal Services/Fitness, Wellness & Personal Training/Health Coaching & Lifestyle Wellness

Keywords

• Telehealth weight loss
• GLP-1 medications
• Virtual nutrition counseling
• Obesity medicine care
• Online weight management

Headquarters

HQ city

Los Angeles

HQ country

United States

HQ region

North America

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Supply Chain, Others

Revenue model

1. Membership subscriptions: Monthly membership fees for access to video visits with weight loss providers, dietitians, prescription support, and app-based tracking and chat features. Insurance members pay reduced first-month pricing ($9), while self-pay members pay $99/month. The membership does not include medication costs or lab fees.
2. Nutrition counseling visits: One-on-one video visits with registered dietitians for personalized nutrition plans. Most insurance patients pay $0; self-pay is $125 per 50-minute visit with no ongoing subscription required.
3. Compounded medications (self-pay): Self-pay compounded semaglutide ($99/month) and tirzepatide ($166/month) offered when patients lack insurance coverage or prefer not to use insurance for brand-name medications.
4. Lab testing: Flat-rate lab testing at $75 for patients without insurance. Labs are typically covered by insurance for insured patients.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Shapely is a physician-led telehealth platform that delivers medically supervised weight loss care, including monthly video visits with board-certified weight loss providers, prescriptions for GLP-1 medications (semaglutide and tirzepatide, plus brand-name Ozempic, Wegovy, Mounjaro, Zepbound, Foundayo and Contrave), and one-on-one registered dietitian support. Services are accessed via the Shapely website and mobile app, billed through insurance (Medicare and major PPO plans) or via self-pay subscriptions, with compounded semaglutide and tirzepatide available to self-pay patients.

Product overview

Shapely is a telehealth platform offering two integrated services: a Weight Loss Program providing video visits with board-certified providers, GLP-1 medication prescriptions (including Semaglutide, Tirzepatide, Ozempic®, Wegovy®, Zepbound®, Mounjaro®, Foundayo™, and Contrave®), and a Nutrition Program offering virtual dietitian counseling. The platform includes a mobile app for tracking, chat support, and insurance verification. Services are available via insurance (Medicare and major PPO plans) or self-pay, with membership starting at $9/month for insured patients or $49-99/month self-pay.

Differentiator

Problem solved

Functional benefit

Products and services

• Shapely Weight Loss Program A telehealth weight loss program offering monthly video visits with board-certified weight loss providers, weight loss prescriptions (GLP-1 medications) when medically appropriate, insurance navigation and prior authorization support, and access to medications at local pharmacies. Available to adults 18+ in California, Florida, New York, and Texas via insurance ($9 first month) or self-pay ($49-99/month).
• Shapely Nutrition Program Virtual nutrition counseling with registered dietitians, including one-on-one video visits, personalized nutrition plans, and ongoing dietary support for weight management, diabetes, prediabetes, gut health, PCOS, menopause, and heart health. Covered by most PPO plans and Medicare (94% of patients pay $0); self-pay at $125 per 50-minute visit.
• Shapely Mobile App A mobile application for Shapely members featuring food and activity tracking, 24/7 chat support with the care team, smart scale connectivity, insurance coverage verification, and access to educational content.
• Compounded Semaglutide (Self-Pay) Cash-pay compounded semaglutide (GLP-1 receptor agonist) starting at $99/month, available to self-pay patients seeking an affordable weight loss medication alternative when insurance coverage for brand-name Ozempic or Wegovy is unavailable.
• Compounded Tirzepatide (Self-Pay) Cash-pay compounded tirzepatide (GLP-1/GIP dual receptor agonist) starting at $166/month, available to self-pay patients seeking an affordable alternative when brand-name Mounjaro or Zepbound is not covered by insurance.
• Shapely Lab Testing Lab testing at a $75 flat rate for uninsured patients, typically covered by insurance for insured patients, available through Quest Diagnostics (not available in New York).

Quantifiable outcome

• Average 15% body weight loss with FDA-approved GLP-1 medications (Ozempic, Wegovy) combined with diet and exercise
• +3 more outcomes

Named customers6 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• BlueSleepcoreStrategic or Co-development Partner · 11 March 2024Shapely and BlueSleep partnered to provide patients with comprehensive weight loss and sleep apnea care. Shapely offers GLP-1 medications and nutrition support while BlueSleep provides sleep apnea diagnosis and treatment (CPAP, oral appliances). Patients can be fast-tracked between both services for coordinated care.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Noom Health: DTC weight management platform that has added clinician-prescribed GLP-1s and telehealth visits to its behavior-change coaching — competing for the same patient with a more coaching-led, less physician-led model.
• Ro: Ro operates a multi-condition DTC telehealth platform that includes insurance-covered GLP-1 weight loss, physician visits, and ongoing care management — directly mirroring Shapely's model, at much larger scale and with hundreds of millions in venture funding.
• Form Health: Obesity medicine telehealth practice staffed by board-certified physicians offering insurance-covered weight loss with GLP-1s — a clinical-quality peer to Shapely's physician-led, in-network approach.
• Henry Meds: DTC telehealth provider specializing in cash-pay GLP-1 weight loss prescriptions and ongoing care — competing with Shapely's self-pay compounded medication offering for uninsured patients.
• Found: DTC telehealth weight loss platform offering clinician visits, GLP-1 prescribing, and behavior change coaching. Overlaps directly with Shapely on care model, medication mix, and target patient.
• WeightWatchers Clinic (formerly Sequence): WW's clinician-led telehealth weight loss program combining GLP-1 prescribing with coaching and the WW app — directly overlapping Shapely on medications, telehealth, and chronic-condition positioning.
• Alpha Medical: Women's-focused DTC telehealth platform that has expanded into weight management and GLP-1 prescribing, with insurance billing and ongoing care — a closely comparable virtual care delivery model.
• Calibrate: Telehealth metabolic health program combining clinician-prescribed GLP-1s with coaching and curriculum, offered DTC and through employer benefits — a directly comparable physician-plus-coaching model.
• Hims & Hers Health: Public telehealth company that has rapidly expanded into GLP-1 weight loss, with similar subscription pricing, prescriber-led care, and DTC marketing — directly competing for the same patient segment as Shapely.

Regional players

• Eucalyptus: Australia-based telehealth platform that operates dedicated weight loss and GLP-1 clinics under consumer brands — a regionally distinct but structurally identical multi-brand telehealth weight loss model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/shapelyweightloss
• LinkedInlinkedin.com/company/getshapely

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Shapely